Treatment of Cold and Cough in Elderly Patients

Initial Assessment and Diagnosis

The American College of Chest Physicians recommends excluding pneumonia by checking for tachycardia, tachypnea, or fever with systemic illness, abnormal chest findings, and significant hemoptysis, progressive breathlessness, or voice changes requiring immediate referral in elderly patients with cold and cough symptoms 1, 2

The American Academy of Family Physicians suggests using first-generation antihistamine/decongestant combinations as first-line therapy for nasal symptoms in elderly patients with cold and cough, while avoiding these medications in patients with glaucoma, benign prostatic hypertrophy, or uncontrolled hypertension 1, 3, 2
The American College of Chest Physicians recommends dextromethorphan 60 mg as the preferred antitussive for bothersome cough in elderly patients, with a maximum cough suppression and superior safety profile compared to codeine 3, 2, 4

The European Respiratory Society suggests using simple home remedies like honey and lemon as initial cost-effective approaches without adverse effects for cold and cough symptoms in elderly patients 3, 2, 4
The American Thoracic Society recommends ipratropium bromide nasal spray as the only inhaled anticholinergic for cough suppression in upper respiratory infections in elderly patients 1, 5, 4

The American Geriatrics Society advises against prescribing antibiotics for uncomplicated viral cold, as they provide no benefit, and avoiding combination products containing excessive paracetamol when using higher-dose dextromethorphan in elderly patients 3, 2
The American College of Chest Physicians recommends avoiding over-the-counter combination products unless they contain older antihistamine/decongestant ingredients, and monitoring carefully for urinary retention, insomnia, jitteriness, tachycardia, or worsening hypertension from decongestants in elderly patients 1, 2, 5

The American Thoracic Society recommends simple demulcents, such as honey and lemon mixtures, as a first-line treatment for cough in elderly patients due to their low cost, minimal side effects, and reasonable efficacy 6, 7, 8
Dextromethorphan is the preferred antitussive for elderly patients, with a therapeutic dosing of 10-15 mg three to four times daily, and a maximum daily dose of 120 mg 6

The American College of Chest Physicians recommends avoiding cough syrups containing pseudoephedrine or phenylephrine in elderly patients with hypertension, heart disease, or benign prostatic hypertrophy 9, 10
Codeine, hydrocodone, and other opioid antitussives offer no efficacy advantage over dextromethorphan but carry significantly greater adverse effects, including constipation, sedation, confusion, and respiratory depression in elderly patients 9, 10

The British Thoracic Society recommends obtaining a chest radiograph in elderly patients with risk factors for lung cancer, hemoptysis, progressive breathlessness, or voice changes 9, 10
If cough persists beyond 3 weeks, the American College of Chest Physicians recommends discontinuing symptomatic treatment and pursuing diagnostic workup rather than continued suppression 6, 8

The American Thoracic Society recommends an initial assessment to rule out pneumonia, aspiration risk, and serious underlying disease, followed by a first-line treatment with simple demulcents for 3-5 days 6, 7
The American College of Chest Physicians recommends reassessing the patient if no improvement is seen after 3 weeks, and pursuing diagnostic evaluation rather than continued empiric suppression 6

The American College of Chest Physicians recommends butamirate citrate as a first-line pharmacological option for dry cough, particularly when simple demulcents like honey and lemon are insufficient, with a high level of evidence 11, 12

The American College of Chest Physicians suggests starting with simple demulcents, such as honey and lemon, as the initial cost-effective approach with minimal side effects for dry cough, before considering butamirate citrate 11, 12
Butamirate citrate linctus is recommended as the next step when demulcents fail or for more bothersome dry cough that interferes with daily activities or sleep, according to the American College of Chest Physicians 11, 12

The CHEST guidelines specifically suggest butamirate linctus as part of initial pharmacological management for cough in lung cancer patients, with evidence from a double-blind randomized trial showing significant improvements in the lung cancer subgroup, with a moderate level of evidence 11

Reserve opioid derivatives, such as pholcodine, hydrocodone, dihydrocodeine, or morphine, only for cough that does not respond to demulcents and non-opioid options, as recommended by the American College of Chest Physicians 11, 12
Butamirate is preferred over codeine because codeine offers no efficacy advantage but carries a significantly greater side effect profile, including constipation, sedation, and respiratory depression risk, according to the American College of Chest Physicians 11
Ensure adequate dosing of butamirate per product labeling, as many over-the-counter preparations contain subtherapeutic doses, as noted by the American College of Chest Physicians 11